BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu Z, Lu Z, Li L, Ma M, Long F, Wu R, Huang L, Chou J, Yang K, Zhang Y, Li X, Hu G, Zhang Y, Lin C. Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer. Front Immunol 2021;12:783362. [PMID: 35154072 DOI: 10.3389/fimmu.2021.783362] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 19.0] [Reference Citation Analysis]
Number Citing Articles
1 Wu Z, Fang ZX, Hou YY, Wu BX, Deng Y, Wu HT, Liu J. Review of ferroptosis in colorectal cancer: Friends or foes? World J Gastroenterol 2023; 29(3): 469-486 [PMID: 36688016 DOI: 10.3748/wjg.v29.i3.469] [Reference Citation Analysis]
2 Mao Z, Nie Y, Jia W, Wang Y, Li J, Zhang T, Lei X, Shi W, Song W, Zhang X. Revealing Prognostic and Immunotherapy-Sensitive Characteristics of a Novel Cuproptosis-Related LncRNA Model in Hepatocellular Carcinoma Patients by Genomic Analysis. Cancers (Basel) 2023;15. [PMID: 36672493 DOI: 10.3390/cancers15020544] [Reference Citation Analysis]
3 Jiao Y, Geng R, Zhong Z, Ni S, Liu W, He Z, Gan S, Huang Q, Liu J, Bai J. A Hypoxia Molecular Signature-Based Prognostic Model for Endometrial Cancer Patients. Int J Mol Sci 2023;24. [PMID: 36675190 DOI: 10.3390/ijms24021675] [Reference Citation Analysis]
4 Chen H, Peng L, Zhou D, Tan N, Qu G. A risk stratification and prognostic prediction model for lung adenocarcinoma based on aging-related lncRNA. Sci Rep 2023;13:460. [PMID: 36627319 DOI: 10.1038/s41598-022-26897-2] [Reference Citation Analysis]
5 Vivarelli S, Costa C, Teodoro M, Giambò F, Tsatsakis AM, Fenga C. Polyphenols: a route from bioavailability to bioactivity addressing potential health benefits to tackle human chronic diseases. Arch Toxicol 2023;97:3-38. [PMID: 36260104 DOI: 10.1007/s00204-022-03391-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Hu B, Yin Y, Li S, Guo X. Insights on Ferroptosis and Colorectal Cancer: Progress and Updates. Molecules 2022;28. [PMID: 36615434 DOI: 10.3390/molecules28010243] [Reference Citation Analysis]
7 Liu B, Pang K, Feng C, Liu Z, Li C, Zhang H, Liu P, Li Z, He S, Tu C. Comprehensive analysis of a novel cuproptosis-related lncRNA signature associated with prognosis and tumor matrix features to predict immunotherapy in soft tissue carcinoma. Front Genet 2022;13:1063057. [PMID: 36568384 DOI: 10.3389/fgene.2022.1063057] [Reference Citation Analysis]
8 Zhou M, Deng Y, Fu Y, Liang R, Wang B, Liu Y, Liao Q. A new prognostic model for GBM based on coagulation-related genes.. [DOI: 10.21203/rs.3.rs-2327672/v1] [Reference Citation Analysis]
9 Sun M, Ji X, Xie M, Chen X, Zhang B, Luo X, Feng Y, Liu D, Wang Y, Li Y, Liu B, Xia L, Huang W. Identification of necroptosis-related subtypes, development of a novel signature, and characterization of immune infiltration in colorectal cancer. Front Immunol 2022;13:999084. [PMID: 36544770 DOI: 10.3389/fimmu.2022.999084] [Reference Citation Analysis]
10 Chen K, Wang J, Xiao J, Li Z, Zhao X, Chen X, Meng X, Feng J. A novel cuproptosis-related prognostic long non-coding RNAs signature model in neuroblastoma.. [DOI: 10.21203/rs.3.rs-2259371/v1] [Reference Citation Analysis]
11 Cui J, Guo F, Yu Y, Ma Z, Hong Y, Su J, Ge Y. Development and validation of a prognostic 9-gene signature for colorectal cancer. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1009698] [Reference Citation Analysis]
12 Rong Xu, Xin Wu, Ashuai Du, Qiangqiang Zhao, He Huang. Identification of cuproptosis-related long non-coding ribonucleic acid signature as a novel prognosis model for colon cancer. Am J Cancer Res 2022;12. [PMID: 36504883] [Reference Citation Analysis]
13 Zan Li, Junyi Yu, Chunliu Lv, Zhenhua Luo. Cancer-associated fibroblasts-derived lncRNA signature as a putative biomarker in breast cancer. Front Oncol 2022;12:1028664. [PMID: 36408190 DOI: 10.3389/fonc.2022.1028664] [Reference Citation Analysis]
14 Li P, Lv X, Liu L, Peng M, Qin D. The Role of Ferroptosis-Related Molecules and Significance of Ferroptosis Score in Cervical Cancer. Journal of Oncology 2022;2022:1-18. [DOI: 10.1155/2022/7835698] [Reference Citation Analysis]
15 Zhou N, Yuan X, Du Q, Zhang Z, Shi X, Bao J, Ning Y, Peng L. FerrDb V2: update of the manually curated database of ferroptosis regulators and ferroptosis-disease associations. Nucleic Acids Res 2023;51:D571-82. [PMID: 36305834 DOI: 10.1093/nar/gkac935] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Zhou M, Lv S, Hou Y, Zhang R, Wang W, Yan Z, Li T, Gan W, Zeng Z, Zhang F, Yang M. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer. Front Immunol 2022;13:994874. [DOI: 10.3389/fimmu.2022.994874] [Reference Citation Analysis]
17 Xu C, Li F, Liu Z, Yan C, Xiao J. A novel cell senescence-related IncRNA survival model associated with the tumor immune environment in colorectal cancer. Front Immunol 2022;13:1019764. [DOI: 10.3389/fimmu.2022.1019764] [Reference Citation Analysis]
18 Chen J, Liu Y, Xu K, Ren F, Li B, Sun H. Establishment and validation of a clinicopathological prognosis model of gastroenteropancreatic neuroendocrine carcinomas. Front Oncol 2022;12:999012. [DOI: 10.3389/fonc.2022.999012] [Reference Citation Analysis]
19 Li J, Fu Y, Zhang K, Li Y. Integration of Bulk and Single-Cell RNA-Seq Data to Construct a Prognostic Model of Membrane Tension-Related Genes for Colon Cancer. Vaccines (Basel) 2022;10:1562. [PMID: 36146640 DOI: 10.3390/vaccines10091562] [Reference Citation Analysis]
20 Wang Y, Huang X, Chen S, Jiang H, Rao H, Lu L, Wen F, Pei J. In Silico Identification and Validation of Cuproptosis-Related LncRNA Signature as a Novel Prognostic Model and Immune Function Analysis in Colon Adenocarcinoma. Current Oncology 2022;29:6573-6593. [DOI: 10.3390/curroncol29090517] [Reference Citation Analysis]
21 Wu Z, Zhang F, Wang Y, Lu Z, Lin C. Identification and Validation of the lncRNA MYOSLID as a Regulating Factor of Necroptosis and Immune Cell Infiltration in Colorectal Cancer following Necroptosis-Related LncRNA Model Establishment. Cancers 2022;14:4364. [DOI: 10.3390/cancers14184364] [Reference Citation Analysis]
22 Wu J, Sun X. Construction of a ferroptosis-associated circRNA-miRNA-mRNA network in age-related macular degeneration. Exp Eye Res 2022;:109234. [PMID: 36044964 DOI: 10.1016/j.exer.2022.109234] [Reference Citation Analysis]
23 Yang L, Chen Z, Liu Y, Wang X, Li J, Ye Q. Immunization Combined with Ferroptosis Related Genes to Construct a New Prognostic Model for Head and Neck Squamous Cell Carcinoma. Cancers 2022;14:4099. [DOI: 10.3390/cancers14174099] [Reference Citation Analysis]
24 Pan H, Pan J, Wu J. Development and validation of a cancer-associated fibroblast-derived lncRNA signature for predicting clinical outcomes in colorectal cancer. Front Immunol 2022;13:934221. [DOI: 10.3389/fimmu.2022.934221] [Reference Citation Analysis]
25 Xu M, Mu J, Wang J, Zhou Q, Wang J. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma. Front Oncol 2022;12:961213. [DOI: 10.3389/fonc.2022.961213] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
26 Wang L, Sun J. ASPN Is a Potential Biomarker and Associated with Immune Infiltration in Endometriosis. Genes 2022;13:1352. [DOI: 10.3390/genes13081352] [Reference Citation Analysis]
27 Liu B, Liu Z, Feng C, Tu C. A Necroptosis-Related lncRNA Signature Predicts Prognosis and Indicates the Immune Microenvironment in Soft Tissue Sarcomas. Front Genet 2022;13:899545. [DOI: 10.3389/fgene.2022.899545] [Reference Citation Analysis]
28 Xu S, Zhou Y, Luo J, Chen S, Xie J, Liu H, Wang Y, Li Z. Integrated Analysis of a Ferroptosis-Related LncRNA Signature for Evaluating the Prognosis of Patients with Colorectal Cancer. Genes (Basel) 2022;13:1094. [PMID: 35741856 DOI: 10.3390/genes13061094] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Yang J, Chen Z, Gong Z, Li Q, Ding H, Cui Y, Tang L, Li S, Wan L, Li Y, Ju S, Ding C, Zhao J. Immune Landscape and Classification in Lung Adenocarcinoma Based on a Novel Cell Cycle Checkpoints Related Signature for Predicting Prognosis and Therapeutic Response. Front Genet 2022;13:908104. [PMID: 35646074 DOI: 10.3389/fgene.2022.908104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Zhang Z, Wang F, Zhang J, Zhan W, Zhang G, Li C, Zhang T, Yuan Q, Chen J, Guo M, Xu H, Yu F, Wang H, Wang X, Kong W. An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma. Front Pharmacol 2022;13:854851. [PMID: 35431958 DOI: 10.3389/fphar.2022.854851] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Yang Q, Al-Hendy A. The Regulatory Functions and the Mechanisms of Long Non-Coding RNAs in Cervical Cancer. Cells 2022;11:1149. [PMID: 35406713 DOI: 10.3390/cells11071149] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]